British Patient Capital Backs Notable Cancer Research with $7 million Investment in Grey Wolf Therapeutics
British Patient Capital, a subsidiary of the British Business Bank, invested $7 million in Grey Wolf Therapeutics, an Oxford-based biotech … Read More